Latest News about Moderna Inc
Recent news which mentions Moderna Inc
   Netflix, TSMC, American Express, Moderna, And Tesla: Why These 5 Stocks Are On Investors' Radars Today
   
  
  
  October 17, 2024
  From Benzinga
 
   Novavax says FDA put hold on combination Covid-flu shot and influenza vaccine; shares plunge
   
  
  October 16, 2024
  From CNBC.com News
 
   Cramer's Lightning Round: 'Buy more' Pfizer
   
  
  September 17, 2024
  From CNBC.com News
 
   5 things to know before the stock market opens Thursday
   
  
  September 12, 2024
  From CNBC.com News
 
   Moderna to cut $1.1 billion in costs and launch 10 new products by 2027 as it charts post-Covid future
   
  
  September 12, 2024
  From CNBC.com News
 From CNBC.com News
 
   Healthy Returns: What to know about the latest round of Pfizer, Moderna Covid vaccines
   
  
  August 27, 2024
  From CNBC.com News
 From CNBC.com News
 
   5 things to know before the stock market opens Friday
   
  
  August 23, 2024
  From CNBC.com News
 
   CNBC Daily Open: Stocks slide ahead of Powell speech
   
  
  August 22, 2024
  From CNBC.com News
 
   FDA approves updated Pfizer, Moderna Covid vaccines as virus surges; shots to be available within days
   
  
  August 22, 2024
  From CNBC.com News
 
   Healthy Returns: The race to develop combination shots targeting Covid, flu is heating up
   
  
  August 20, 2024
  From CNBC.com News
 From CNBC.com News
 
   Moderna beats estimates but slashes guidance on low EU sales, competitive U.S. vaccine market
   
  
  August 01, 2024
  From CNBC.com News
 
   Pfizer struggles to claw back faith with Wall Street and its employees as it recovers from the Covid decline
   
  
  June 28, 2024
  From CNBC.com News
 From CNBC.com News
 
   3 actions extraordinary people take to achieve what seems impossible, from the co-founder of Moderna
   
  
  June 11, 2024
  From CNBC.com News
 
   5 things to know before the stock market opens
   
  
  June 11, 2024
  From CNBC.com News
 
   Moderna's combination Covid, flu vaccine is more effective than existing shots in late-stage trial
   
  
  June 10, 2024
  From CNBC.com News
 
   FDA approves GSK's RSV vaccine for high-risk adults ages 50 to 59, expanding shot's reach
   
  
  June 07, 2024
  From CNBC.com News
 
   Healthy Returns: Drugmakers release promising cancer drug data – and AstraZeneca wins big
   
  
  June 07, 2024
  From CNBC.com News
 From CNBC.com News
 From CNBC.com News
 
   Healthy Returns: Pfizer, Merck, J&J and more to release cancer drug data at industry conference
   
  
  May 30, 2024
  From CNBC.com News
 
   Cramer's Lighting Round: Sell AMC
   
  
  May 24, 2024
  From CNBC.com News
 
   Here's how U.S. health officials are responding to bird flu in humans after second case
   
  
  May 24, 2024
  From CNBC.com News
 From CNBC.com News
 
   Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
  
  
 Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
  © 2025 FinancialContent. All rights reserved.
 
